Company intelligence / Profile preview
Bactolife
Copenhagen, Capital Region, Denmarkbactolife.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Preclinical
01
Overview
The company has proof of concept of its technology from testing its most advanced animal health product, Ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea (PWD), in more than 6,000 piglets[5].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Binding Proteins
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Bactolife.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bactolife.